On November 9, 2021 NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), reported that Aram Mangasarian, Chief Executive Officer of NOXXON, will present at Investir Day 2021, at the Palais Brongniart in Paris on November 23, 2021 and will be available for virtual meetings with participants from November 15 to 23, 2021 (Press release, NOXXON, NOV 9, 2021, View Source [SID1234594936]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details of the presentation are as follow:
Title: "NOXXON Pharma: a specialist in the development of new cancer treatments targeting the tumoral microenvironment" – the presentation will be held in French
Time: Tuesday, November 23, 2021 at 09:35 – 09:55 am CET, at the Palais Brongniart in Paris, France
To register, please click here
To request a one-on-one meeting with Aram Mangasarian, please contact [email protected].